Free Trial
→ The End of Elon Musk…? (From Brownstone Research) (Ad)

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AWWC
Access Worldwide Communications
$0.00
$0.00
$0.00
▼
$0.06
N/A0.934,523 shsN/A
CAME
(CAME)
$0.95
-17.4%		$0.95
$0.75
▼
$1.15
N/AN/AN/A2,200 shs
CLEA
(CLEA)
$0.00
$0.00
▼
$0.00
N/AN/AN/AN/A
Bioheart Inc. stock logo
USRM
Bioheart
$0.00
-50.0%		$0.00
$0.00
▼
$0.00
N/A-1.35100,961 shs123 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover
20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AWWC
Access Worldwide Communications
0.00%0.00%0.00%0.00%0.00%
CAME
(CAME)
0.00%0.00%0.00%0.00%0.00%
Bioheart Inc. stock logo
USRM
Bioheart
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AWWC
Access Worldwide Communications
N/AN/AN/AN/AN/AN/AN/AN/A
CAME
(CAME)
N/AN/AN/AN/AN/AN/AN/AN/A
CLEA
(CLEA)
N/AN/AN/AN/AN/AN/AN/AN/A
Bioheart Inc. stock logo
USRM
Bioheart
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AWWC
Access Worldwide Communications
0.00
N/AN/AN/A
CAME
(CAME)
0.00
N/AN/AN/A
CLEA
(CLEA)
0.00
N/AN/AN/A
Bioheart Inc. stock logo
USRM
Bioheart
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AWWC
Access Worldwide Communications
N/AN/AN/AN/AN/AN/A
CAME
(CAME)
N/AN/AN/AN/AN/AN/A
CLEA
(CLEA)
N/AN/AN/AN/AN/AN/A
Bioheart Inc. stock logo
USRM
Bioheart
$80KN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AWWC
Access Worldwide Communications
N/AN/A0.00∞N/AN/AN/AN/AN/A
CAME
(CAME)
N/AN/A0.00∞N/AN/AN/AN/AN/A
CLEA
(CLEA)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Bioheart Inc. stock logo
USRM
Bioheart
-$2.86MN/A0.00∞N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AWWC
Access Worldwide Communications
N/AN/AN/AN/AN/A
CAME
(CAME)
N/AN/AN/AN/AN/A
CLEA
(CLEA)
N/AN/AN/AN/AN/A
Bioheart Inc. stock logo
USRM
Bioheart
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AWWC
Access Worldwide Communications
N/A
CAME
(CAME)
N/A
CLEA
(CLEA)
N/A
Bioheart Inc. stock logo
USRM
Bioheart
N/A

Insider Ownership

CompanyInsider Ownership
AWWC
Access Worldwide Communications
29.50%
CAME
(CAME)
N/A
CLEA
(CLEA)
N/A
Bioheart Inc. stock logo
USRM
Bioheart
16.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
AWWC
Access Worldwide Communications
1,000N/AN/ANot Optionable
CAME
(CAME)
N/AN/AN/ANot Optionable
CLEA
(CLEA)
N/AN/AN/ANot Optionable
Bioheart Inc. stock logo
USRM
Bioheart
11N/AN/ANot Optionable

Recent News About These Companies

Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments
June 5, 2025  |  nytimes.comhttps://www.nytimes.com/2025/06/05/health/kennedy-stem-cells-experimental-treatments.html
The Allure of Stem Cell Therapy
June 5, 2025  |  nytimes.comhttps://www.nytimes.com/2025/06/05/well/stem-cell-therapy-health.html
How our bones are repaired by skeletal stem cells: Scientist discover four major subtypes
June 4, 2025  |  msn.comhttps://www.msn.com/en-us/health/medical/how-our-bones-are-repaired-by-skeletal-stem-cells-scientist-discover-four-major-subtypes/ar-AA1G5tq2
First Stem Cell Nerve Therapy Meant to Reverse Paralysis Enters Clinical Trial
May 28, 2025  |  msn.comhttps://www.msn.com/en-us/science/biology/first-stem-cell-nerve-therapy-meant-to-reverse-paralysis-enters-clinical-trial/ar-AA1FDNX2
Vascularized stem cell islet organoids offer improved model for diabetes research
May 23, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/vascularized-stem-cell-islet-organoids-offer-improved-model-for-diabetes-research/ar-AA1FmoZb
First successful allogeneic stem cell transplant using deceased donor in blood cancer clinical trial
May 17, 2025  |  sciencex.comS
Stem cells coaxed into most advanced amniotic sacs ever grown in the lab
May 15, 2025  |  nature.comN
Newly discovered ‘super stem cells’ can transform into better versions of themselves
May 7, 2025  |  bgr.comB
Ultrasound and microrobots team up to boost stem cell therapy for brain repair
April 30, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/ultrasound-and-microrobots-team-up-to-boost-stem-cell-therapy-for-brain-repair/ar-AA1DWBBv
A dangerous new push to ban embryonic stem cell research funding is gaining momentum
April 30, 2025  |  statnews.comS
Federal Circuit Affirms Stem Cell Product-by-Process Claims: Lessons in Claim Construction and Inherency from Restem LLV v. Jadi Cell LLC
April 25, 2025  |  jdsupra.comhttps://www.jdsupra.com/legalnews/federal-circuit-affirms-stem-cell-1412870/
Despite political pushback, the Yale Stem Cell Center has emerged as a leader in regenerative medicine
April 25, 2025  |  yaledailynews.comY
New approach targets cell surface protein to treat leukemia and solid tumors
April 24, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/a-new-druggable-cancer-target-rna-binding-proteins-on-the-cell-surface/ar-AA1DrDMW
DNA organization offers clues for advancing stem cell therapy
April 17, 2025  |  news.ucr.eduN
Neural stem cells outside the brain: Discovery opens new paths for regenerative medicine
April 10, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/neural-stem-cells-outside-the-brain-discovery-opens-new-paths-for-regenerative-medicine/ar-AA1CGhZx
World’s first human trial of sperm stem cell therapy aims to reverse male infertility
April 7, 2025  |  msn.comhttps://www.msn.com/en-us/science/genetics/world-s-first-human-trial-of-sperm-stem-cell-therapy-aims-to-reverse-male-infertility/ar-AA1Cs4t4
Drug-delivering aptamers target leukemia stem cells for a one-two knockout punch
April 3, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/drug-delivering-aptamers-target-leukemia-stem-cells-for-a-one-two-knockout-punch/ar-AA1Cfz1c
Sperm Stem Cells Were Used for the First Time in an Attempt to Restore Fertility
March 28, 2025  |  wired.comW
Paralysed man stands again after receiving ‘reprogrammed’ stem cells
March 24, 2025  |  nature.comN
Scientists create universal vascular graft with stem cells to improve surgery for cardiovascular disease
March 10, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/scientists-create-universal-vascular-graft-with-stem-cells-to-improve-surgery-for-cardiovascular-disease/ar-AA1AD8A1

Media Sentiment Over Time

Top Headlines

View All Headlines

Access Worldwide Communications OTCMKTS:AWWC

$0.0041 0.00 (0.00%)
As of 10/24/2022

Access Worldwide Communications, Inc. provides business process outsourcing and marketing solutions. The company offers a range of sales, backoffice, IT, and communication services. It provides inbound/outbound teleservices that include customer service, technical support, sales acquisition and processing, third party verification, dealer locators, coupons/product samples, product recalls, customer acquisition, customer retention, product awareness, win-back campaigns, market research/surveys, lead generation, membership drives, and preferred customer offers. The company also offers B-to-B services, such as customer care, customer acquisition, customer retention, win-back campaigns, and market research services; and agent recruiting/training services. It serves telecommunications providers, insurance companies, financial institutions, and consumer products companies; and credit card, retail/catalog, entertainment, healthcare, public utilities, and media/publishing markets worldwide. The company was formerly known as CulturalAccessWorldwide, Inc. and changed its name to Access Worldwide Communications, Inc. in November 1998. Access Worldwide Communications, Inc. was founded in 1983 and is headquartered in Boca Raton, Florida.

(CAME) OTCMKTS:CAME

$0.95 -0.20 (-17.39%)
As of 10/11/2017

ChinAmerica Andy Movie Entertainment Media Co. is an operating company. The Company provides consulting services on movie and entertainment projects, including pre-production research and strategy, introducing Chinese entertainment companies with American talent and potential partners from Hollywood, California, training and global market consulting, regarding distribution and production in the United States. The Company works with Zhong Mei An Di Yin Shi Wen Hua Chuan Mei Ltd., Co. (Zhong Mei) to create movie projects in both China and the United States. The Company produces movies and documentaries that export the cultural heritage of the People's Republic of China to other countries. The Company also focuses to provide training and global market consulting, production and post-production activities, and particularly the distribution and promotion movies and documentaries in the United States market.

(CLEA) OTCMKTS:CLEA

ClearDebt Group Plc is a United Kingdom-based holding company. The Company, along with its subsidiaries, is principally engaged in the provision of financial advice and appropriate solutions to individuals experiencing personal debt problems. As of June 30, 2010, the Company's subsidiaries included ClearDebt Limited, which is a financial advisor; ClearCash Limited, which is engaged in providing pre-paid card, and Abacus (Financial Consultants) Limited, which is engaged in debt management.

Bioheart stock logo

Bioheart OTCMKTS:USRM

$0.0001 0.00 (-50.00%)
As of 07/2/2025 10:25 AM Eastern

U.S. Stem Cell, Inc., a biotechnology company, engages in the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States. The company's lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's body for enhancing cardiac function in chronic heart failure patients; and AdipoCell, a patient-derived cell therapy for the treatment of acute myocardial infarction, chronic heart ischemia, and lower limb ischemia. Its pipeline products include MyoCell SDF-1, an autologous muscle-derived cellular therapy for enhancing cardiac function in chronic heart failure patients. The company is also developing MyoCath, a deflecting tip needle injection catheter that is used to inject cells into cardiac tissue in therapeutic procedures to treat chronic heart ischemia and congestive heart failure. In addition, it provides physician and patient based regenerative medicine/cell therapy training, cell collection, and cell storage services; and cell collection and treatment kits for humans and animals, as well as operates a cell therapy clinic to provide cellular treatments for patients afflicted with neurological, autoimmune, orthopedic, and degenerative diseases. The company also offers various courses for physicians and other health care professionals. The company was formerly known as Bioheart, Inc. and changed its name to U.S. Stem Cell, Inc. in October 2015. U.S. Stem Cell, Inc. was incorporated in 1999 and is headquartered in Sunrise, Florida.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas